Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-50.32 Mil
% of Total Estimate Gain
-49.88%

Darwin Global Management, Ltd.'s Keros Therapeutics Inc Holding Summary

As of 2025-03-31, Darwin Global Management, Ltd. held - shares of Keros Therapeutics Inc(KROS), totaling N/A. This investment constitutes 0% of their stock portfolio, and Darwin Global Management, Ltd. now holds 0% of the outstanding Keros Therapeutics Inc(KROS) stock.

The initial trade took place in 2021Q1. And since then Darwin Global Management, Ltd. has made 8 purchases of KROS, at an average price of $43.24, for a total of 2.33 Mil shares. In addition, there have been 6 sales at an average price of $21.67 for 2.33 Mil shares. Based on historical transaction data and KROS's current price of $13.45, Darwin Global Management, Ltd.'s estimated gain on his KROS holdings is $-50.32 Mil, reflecting a -49.88% gain to date.

Darwin Global Management, Ltd. KROS ($13.45) Holding Chart

Darwin Global Management, Ltd. KROS ($13.45) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1